financetom
Business
financetom
/
Business
/
Mike Tyson sued in UK for ditching promotion deal to fight Jake Paul
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mike Tyson sued in UK for ditching promotion deal to fight Jake Paul
Dec 6, 2024 10:09 AM

LONDON, Dec 6 (Reuters) - Mike Tyson is being sued in a London court for nearly 1.5 million euros ($1.59 million) for allegedly breaking a deal to promote a gambling company in order to fight social media influencer-turned-prizefighter Jake Paul.

Medier, a Cyprus-registered company that promotes online casino and betting company Rabona, is suing the former heavyweight champion and his company Tyrannic for allegedly reneging on the deal, which was agreed in January.

The lawsuit, filed at London's High Court in October, says Tyson terminated the deal in March - the same day his fight with Paul was announced - because Medier breached their agreement.

Medier's lawyers, however, argue its actions did not constitute a breach of the deal and that Tyson's breach of contract has caused Medier losses of around 1.46 million euros.

"The true reason for Mr Tyson and Tyrannic's hasty and unlawful termination was because Mr Tyson had agreed a deal, sponsored by Netflix ( NFLX ), to fight the influencer Jake Paul," the company's lawyer said in documents made public on Friday.

Tyson and Tyrannic have yet to file a defence to the lawsuit and Tyson was not immediately available to comment.

Paul, 27, beat the 58-year-old Tyson by unanimous decision in Texas last month, in a fight streamed live on Netflix ( NFLX ) that failed to live up to its enormous hype.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Murphy Usa Insider Sold Shares Worth $1,023,080, According to a Recent SEC Filing
Murphy Usa Insider Sold Shares Worth $1,023,080, According to a Recent SEC Filing
Aug 28, 2024
06:01 PM EDT, 08/28/2024 (MT Newswires) -- James W Keyes, Director, on August 27, 2024, sold 2,000 shares in Murphy Usa ( MUSA ) for $1,023,080. Following the Form 4 filing with the SEC, Keyes has control over a total of 16,114 shares of the company, with 16,114 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1573516/000112760224023085/xslF345X05/form4.xml Price: 514.60, Change: -0.21, Percent Change:...
Applied Digital Swings to Fiscal Q4 Adjusted Loss, Revenue Increases
Applied Digital Swings to Fiscal Q4 Adjusted Loss, Revenue Increases
Aug 28, 2024
05:34 PM EDT, 08/28/2024 (MT Newswires) -- Applied Digital ( APLD ) reported a fiscal Q4 adjusted net loss late Wednesday of $0.36 per diluted share, compared with no earnings a year earlier. Three analysts polled by Capital IQ expected a loss of $0.22 per share. Revenue for the quarter ended May 31 was $43.7 million, up from $22 million...
Loandepot Insider Sold Shares Worth $1,895,822, According to a Recent SEC Filing
Loandepot Insider Sold Shares Worth $1,895,822, According to a Recent SEC Filing
Aug 28, 2024
05:31 PM EDT, 08/28/2024 (MT Newswires) -- Anthony Li Hsieh, 10% Owner, Director, on August 26, 2024, sold 639,186 shares in Loandepot ( LDI ) for $1,895,822. Following the Form 4 filing with the SEC, Hsieh has control over a total of 2,480,026 shares of the company, with 89,566 shares held directly and 2,390,460 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1831631/000183163124000212/xslF345X05/wk-form4_1724880449.xml Price:...
Qiagen Expands Master Collaboration Agreement with AstraZeneca
Qiagen Expands Master Collaboration Agreement with AstraZeneca
Aug 28, 2024
05:31 PM EDT, 08/28/2024 (MT Newswires) -- Qiagen ( QGEN ) said late Wednesday it is expanding its master collaboration agreement with AstraZeneca ( AZN ) . Qiagen ( QGEN ) will use its QIAstat-Dx syndromic testing platform to develop and validate a genotyping assay that will allow specialty care providers to potentially perform genotyping while patients are undergoing routine...
Copyright 2023-2025 - www.financetom.com All Rights Reserved